Comprehensive Financial Management’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.6M | Hold |
2,207,619
| – | – | 0.04% | 29 |
|
2025
Q1 | $1.9M | Hold |
2,207,619
| – | – | 0.06% | 22 |
|
2024
Q4 | $3.71M | Sell |
2,207,619
-1
| -0% | -$2 | 0.1% | 16 |
|
2024
Q3 | $6.29M | Hold |
2,207,620
| – | – | 0.18% | 16 |
|
2024
Q2 | $5.17M | Buy |
2,207,620
+1
| +0% | +$2 | 0.18% | 16 |
|
2024
Q1 | $6.49M | Hold |
2,207,619
| – | – | 0.21% | 16 |
|
2023
Q4 | $6.6M | Hold |
2,207,619
| – | – | 0.23% | 14 |
|
2023
Q3 | $6.98M | Hold |
2,207,619
| – | – | 0.25% | 15 |
|
2023
Q2 | $8.54M | Sell |
2,207,619
-17,000
| -0.8% | -$65.8K | 0.28% | 12 |
|
2023
Q1 | $6.16M | Hold |
2,224,619
| – | – | 0.19% | 14 |
|
2022
Q4 | $4M | Hold |
2,224,619
| – | – | 0.13% | 19 |
|
2022
Q3 | $4.72M | Hold |
2,224,619
| – | – | 0.12% | 18 |
|
2022
Q2 | $5.98M | Hold |
2,224,619
| – | – | 0.17% | 17 |
|
2022
Q1 | $9.66M | Hold |
2,224,619
| – | – | 0.17% | 15 |
|
2021
Q4 | $11.5M | Hold |
2,224,619
| – | – | 0.15% | 17 |
|
2021
Q3 | $13.7M | Hold |
2,224,619
| – | – | 0.13% | 14 |
|
2021
Q2 | $22.5M | Buy |
+2,224,619
| New | +$22.5M | 0.19% | 15 |
|